1-methylimidazole has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies
1-methyl-1H-imidazole : A 1H-imidazole having a methyl substituent at the N-1 position.
Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, H | 1 |
| Fukuda, N | 1 |
| Ueno, T | 1 |
| Katakawa, M | 1 |
| Wang, X | 1 |
| Watanabe, T | 1 |
| Matsui, S | 1 |
| Aoyama, T | 1 |
| Saito, K | 1 |
| Bando, T | 1 |
| Matsumoto, Y | 1 |
| Nagase, H | 1 |
| Matsumoto, K | 1 |
| Sugiyama, H | 1 |
1 other study available for 1-methylimidazole and Glomerulosclerosis, Focal Segmental
| Article | Year |
|---|---|
Transcriptional inhibition of progressive renal disease by gene silencing pyrrole-imidazole polyamide targeting of the transforming growth factor-β1 promoter.
Topics: Amino Acids; Animals; Fibrosis; Gene Expression Regulation; Gene Silencing; Genetic Therapy; Glomeru | 2011 |